The practical takeaway If your physician cites animal studies as the primary reason to avoid GLP-1 therapy while breastfeeding, ask about the human lactation data that has since been published
Hypoglycemia: On their own, GLP-1 RAs have negligible hypoglycemia risk
They typically contain active ingredients that break down fat cells, which are then naturally metabolised and eliminated by the body
The consensus among conservative, evidence-driven physicians is that BPC-157 should only be used, if at all, in controlled research settings until its safety is definitively proven
That means your body gets more of what youre paying forand it actually reaches the cells that need it
However, people with a family history of certain thyroid cancers and pancreatitis may need to consider other alternatives